Activation of protein kinase C (PKC) induces angiogenesis, migration, and proliferation of endothelial cells (EC), but can also prevent growth factor-induced EC proliferation. To determine whether these disparate effects are mediated by substrates of individual PKC isoenzymes, PKCā£ and PKCā¦ were overexpressed in rat microvascular EC. Basal and stimulated migration were enhanced in PKCā£ EC compared with either PKCā¦ or control EC. Serum-induced growth of PKCā¦ EC was decreased, while that of PKCā£ cells was similar to control EC. Phorbol ester markedly inhibited PKCā¦ EC growth but enhanced growth of PKCā£ and control EC. To determine possible causes for this altered proliferation, the effect of PKCā¦ on adhesion, mitogen-activated protein kinase activity, and cell cycle progression was measured. Adherence of PKCā¦ EC to vitronectin was significantly enhanced. Serum-induced extracellular signalregulated kinase-2 activity was increased equally in both PKCā£ and PKCā¦ EC above that of control, while extracellular signal-regulated kinase-1 activity was similar in all EC. Cell cycle analysis suggested that PKCā¦ EC entered S phase inappropriately and were delayed in passage through S phase. Thus, PKCā£ may mediate some proangiogenic effects of PKC activation; conversely, PKCā¦ may direct antiangiogenic aspects of overall PKC activation, including slowing of the cell cycle progression.The formation of new blood vessels and the repair of those damaged by disease or injury depend upon endothelial migration and proliferation (1, 2). Several external agents that promote or inhibit proliferation and migration have been identified (3, 4), but the intracellular messengers that mediate these processes are less clear.Activation of the serine-threonine kinase protein kinase C (PKC) 1 by phorbol esters induces migration, proliferation (5), and tube formation of cultured endothelial cells (6, 7) and causes angiogenesis in vivo (7-9). In addition, chemical inhibitors of PKC or the down-regulation of PKC by prolonged treatment with phorbol esters abrogates the proliferative effects induced by growth factors and mitogens (10, 11) and also enhances endothelial permeability (12, 13) and alters the expression level of several fibrinolytic enzymes and their inhibitors (14). In contrast, treatment of endothelial cells with direct activators of PKC alters some responses that are usually associated with stimulation by physiologic agonists (15) and, under some conditions, can prevent growth factor-induced proliferation (16). This apparent paradox might be explained by the fact that the PKC family is composed of related but structurally distinct isoenzymes, each a product of separate genes and with discrete cofactor requirements, substrate specificity, and tissue distribution (16 -18). Since phorbol esters activate multiple isoenzymes of PKC, the possibility is raised that each PKC isoenzyme may selectively mediate separate, and perhaps opposing, effects within stimulated endothelial cells.Preliminary studies in our laboratory revealed that rat capillar...